title: De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?
authors: Benoit J
authors: BJ
authors: Arsenault
authors: S Matthijs
authors: SM
authors: Boekholdt
authors: Jean-Claude
authors: JC
authors: Tardif
authors: John J P
authors: JJ
authors: Kastelein
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects*; D006973:Hypertension / Q000503:physiopathology*; D008297:Male; D011804:Quinolines / Q000494:pharmacology*
chemical_list: D000924:Anticholesteremic Agents; D011804:Quinolines; C483909:torcetrapib